Bristol-Myers Squibb Company (BMY)
USD 49.37
(0.87%)
USD 49.37
(0.87%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 30 Billion USD | -5.05% |
| 2022 | 31.59 Billion USD | -0.07% |
| 2021 | 31.61 Billion USD | -14.84% |
| 2020 | 37.12 Billion USD | 5.5% |
| 2019 | 35.19 Billion USD | 7934.7% |
| 2018 | 438 Million USD | -82.76% |
| 2017 | 2.54 Billion USD | 2.83% |
| 2016 | 2.47 Billion USD | -42.59% |
| 2015 | 4.3 Billion USD | 90.36% |
| 2014 | 2.26 Billion USD | -52.44% |
| 2013 | 4.75 Billion USD | -17.15% |
| 2012 | 5.73 Billion USD | 2113.33% |
| 2011 | -285 Million USD | -169.17% |
| 2010 | 412 Million USD | 131.16% |
| 2009 | -1.32 Billion USD | -6.87% |
| 2008 | -1.23 Billion USD | -127.67% |
| 2007 | 4.47 Billion USD | -17.46% |
| 2006 | 5.41 Billion USD | -2.31% |
| 2005 | 5.54 Billion USD | -16.82% |
| 2004 | 6.66 Billion USD | 7.43% |
| 2003 | 6.2 Billion USD | 69.44% |
| 2002 | 3.66 Billion USD | 301.98% |
| 2001 | 911 Million USD | 154.1% |
| 2000 | -1.68 Billion USD | -78.01% |
| 1999 | -946 Million USD | -137.69% |
| 1998 | -398 Million USD | -208.74% |
| 1997 | 366 Million USD | 281.19% |
| 1996 | -202 Million USD | 53.56% |
| 1995 | -435 Million USD | -59.34% |
| 1994 | -273 Million USD | 83.51% |
| 1993 | -1.65 Billion USD | -4.41% |
| 1992 | -1.58 Billion USD | -112.32% |
| 1991 | -747 Million USD | -2434.38% |
| 1990 | 32 Million USD | 300.0% |
| 1989 | 8 Million USD | 100.52% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 47.7 Billion USD | -0.77% |
| 2024 Q3 | 41.86 Billion USD | -8.8% |
| 2024 Q1 | 48.07 Billion USD | 60.26% |
| 2023 Q4 | 30 Billion USD | -5.52% |
| 2023 Q3 | 31.75 Billion USD | 3.05% |
| 2023 Q2 | 30.81 Billion USD | 1.44% |
| 2023 FY | 30 Billion USD | -5.05% |
| 2023 Q1 | 30.37 Billion USD | -3.86% |
| 2022 FY | 31.59 Billion USD | -0.07% |
| 2022 Q1 | 33.62 Billion USD | 6.35% |
| 2022 Q2 | 32.29 Billion USD | -3.97% |
| 2022 Q3 | 32.37 Billion USD | 0.26% |
| 2022 Q4 | 31.59 Billion USD | -2.42% |
| 2021 Q3 | 32.3 Billion USD | -8.41% |
| 2021 Q2 | 35.26 Billion USD | -2.81% |
| 2021 FY | 31.61 Billion USD | -14.84% |
| 2021 Q1 | 36.28 Billion USD | -2.26% |
| 2021 Q4 | 31.61 Billion USD | -2.13% |
| 2020 Q2 | 27.57 Billion USD | -13.05% |
| 2020 Q4 | 37.12 Billion USD | 40.78% |
| 2020 Q3 | 26.37 Billion USD | -4.37% |
| 2020 Q1 | 31.71 Billion USD | -9.89% |
| 2020 FY | 37.12 Billion USD | 5.5% |
| 2019 Q4 | 35.19 Billion USD | 744.07% |
| 2019 Q1 | -1.27 Billion USD | -392.01% |
| 2019 Q2 | -3.35 Billion USD | -162.63% |
| 2019 FY | 35.19 Billion USD | 7934.7% |
| 2019 Q3 | -5.46 Billion USD | -62.67% |
| 2018 Q2 | 2.38 Billion USD | 1.27% |
| 2018 Q1 | 2.35 Billion USD | -7.2% |
| 2018 FY | 438 Million USD | -82.76% |
| 2018 Q4 | 438 Million USD | -76.94% |
| 2018 Q3 | 1.89 Billion USD | -20.48% |
| 2017 Q4 | 2.54 Billion USD | -33.11% |
| 2017 Q3 | 3.79 Billion USD | -19.97% |
| 2017 Q2 | 4.74 Billion USD | 4.93% |
| 2017 Q1 | 4.52 Billion USD | 83.08% |
| 2017 FY | 2.54 Billion USD | 2.83% |
| 2016 Q1 | 4.05 Billion USD | -5.79% |
| 2016 Q2 | 3.8 Billion USD | -6.24% |
| 2016 Q3 | 3.39 Billion USD | -10.73% |
| 2016 Q4 | 2.47 Billion USD | -27.2% |
| 2016 FY | 2.47 Billion USD | -42.59% |
| 2015 Q2 | 3.17 Billion USD | 172.66% |
| 2015 Q3 | 3.29 Billion USD | 4.04% |
| 2015 Q4 | 4.3 Billion USD | 30.46% |
| 2015 FY | 4.3 Billion USD | 90.36% |
| 2015 Q1 | 1.16 Billion USD | -48.56% |
| 2014 FY | 2.26 Billion USD | -52.44% |
| 2014 Q1 | 2.42 Billion USD | -49.03% |
| 2014 Q2 | 3.45 Billion USD | 42.59% |
| 2014 Q3 | 2.81 Billion USD | -18.47% |
| 2014 Q4 | 2.26 Billion USD | -19.74% |
| 2013 Q2 | 5.38 Billion USD | -17.65% |
| 2013 Q1 | 6.53 Billion USD | 13.96% |
| 2013 FY | 4.75 Billion USD | -17.15% |
| 2013 Q4 | 4.75 Billion USD | -12.63% |
| 2013 Q3 | 5.44 Billion USD | 1.04% |
| 2012 Q1 | 3.1 Billion USD | 1190.53% |
| 2012 Q3 | 5.85 Billion USD | 121.48% |
| 2012 Q4 | 5.73 Billion USD | -2.02% |
| 2012 FY | 5.73 Billion USD | 2113.33% |
| 2012 Q2 | 2.64 Billion USD | -14.93% |
| 2011 Q3 | 1.14 Billion USD | -38.08% |
| 2011 Q4 | -285 Million USD | -124.83% |
| 2011 FY | -285 Million USD | -169.17% |
| 2011 Q1 | 2 Billion USD | 386.89% |
| 2011 Q2 | 1.85 Billion USD | -7.58% |
| 2010 Q1 | 1.15 Billion USD | 187.29% |
| 2010 FY | 412 Million USD | 131.16% |
| 2010 Q4 | 412 Million USD | 147.96% |
| 2010 Q3 | -859 Million USD | -238.55% |
| 2010 Q2 | 620 Million USD | -46.27% |
| 2009 Q4 | -1.32 Billion USD | -684.96% |
| 2009 Q1 | -1.18 Billion USD | 4.28% |
| 2009 Q2 | -1.14 Billion USD | 3.04% |
| 2009 FY | -1.32 Billion USD | -6.87% |
| 2009 Q3 | 226 Million USD | 119.69% |
| 2008 Q1 | 3.99 Billion USD | -10.58% |
| 2008 Q3 | -918 Million USD | -124.33% |
| 2008 Q2 | 3.77 Billion USD | -5.63% |
| 2008 FY | -1.23 Billion USD | -127.67% |
| 2008 Q4 | -1.23 Billion USD | -34.75% |
| 2007 Q1 | 5.15 Billion USD | -4.76% |
| 2007 Q2 | 4.85 Billion USD | -5.89% |
| 2007 Q3 | 4.48 Billion USD | -7.72% |
| 2007 Q4 | 4.47 Billion USD | -0.2% |
| 2007 FY | 4.47 Billion USD | -17.46% |
| 2006 Q1 | 6.03 Billion USD | 8.84% |
| 2006 FY | 5.41 Billion USD | -2.31% |
| 2006 Q3 | 5.63 Billion USD | -3.31% |
| 2006 Q2 | 5.82 Billion USD | -3.46% |
| 2006 Q4 | 5.41 Billion USD | -3.83% |
| 2005 FY | 5.54 Billion USD | -16.82% |
| 2005 Q1 | 5.25 Billion USD | -21.11% |
| 2005 Q2 | 4.5 Billion USD | -14.39% |
| 2005 Q3 | 4.04 Billion USD | -10.2% |
| 2005 Q4 | 5.54 Billion USD | 37.15% |
| 2004 Q1 | 6.34 Billion USD | 2.27% |
| 2004 FY | 6.66 Billion USD | 7.43% |
| 2004 Q4 | 6.66 Billion USD | -2.1% |
| 2004 Q3 | 6.8 Billion USD | 9.35% |
| 2004 Q2 | 6.22 Billion USD | -1.88% |
| 2003 Q4 | 6.2 Billion USD | 65.2% |
| 2003 FY | 6.2 Billion USD | 69.44% |
| 2003 Q1 | 4.28 Billion USD | 17.04% |
| 2003 Q2 | 4.01 Billion USD | -6.28% |
| 2003 Q3 | 3.75 Billion USD | -6.5% |
| 2002 Q1 | 3.09 Billion USD | 239.85% |
| 2002 Q2 | 3.37 Billion USD | 9.11% |
| 2002 FY | 3.66 Billion USD | 301.98% |
| 2002 Q3 | 3.44 Billion USD | 1.87% |
| 2002 Q4 | 3.66 Billion USD | 6.42% |
| 2001 Q4 | 911 Million USD | -82.45% |
| 2001 FY | 911 Million USD | 154.1% |
| 2001 Q3 | 5.19 Billion USD | 450.81% |
| 2001 Q2 | -1.48 Billion USD | -30.17% |
| 2001 Q1 | -1.13 Billion USD | 32.48% |
| 2000 FY | -1.68 Billion USD | -78.01% |
| 2000 Q1 | -770 Million USD | 18.6% |
| 2000 Q2 | -634 Million USD | 17.66% |
| 2000 Q3 | -1.26 Billion USD | -99.37% |
| 2000 Q4 | -1.68 Billion USD | -33.23% |
| 1999 Q3 | -612 Million USD | -194.23% |
| 1999 Q4 | -946 Million USD | -54.58% |
| 1999 FY | -946 Million USD | -137.69% |
| 1999 Q2 | -208 Million USD | -110.1% |
| 1999 Q1 | -99 Million USD | 75.13% |
| 1998 Q2 | 784 Million USD | 115.38% |
| 1998 FY | -398 Million USD | -208.74% |
| 1998 Q1 | 364 Million USD | -0.55% |
| 1998 Q3 | 287 Million USD | -63.39% |
| 1998 Q4 | -398 Million USD | -238.68% |
| 1997 FY | 366 Million USD | 281.19% |
| 1997 Q3 | 141 Million USD | 41.0% |
| 1997 Q4 | 366 Million USD | 159.57% |
| 1997 Q1 | -255 Million USD | -26.24% |
| 1997 Q2 | 100 Million USD | 139.22% |
| 1996 Q3 | -212 Million USD | -278.57% |
| 1996 Q1 | -153 Million USD | 64.83% |
| 1996 Q2 | -56 Million USD | 63.4% |
| 1996 FY | -202 Million USD | 53.56% |
| 1996 Q4 | -202 Million USD | 4.72% |
| 1995 Q4 | -435 Million USD | -26.82% |
| 1995 Q2 | -208 Million USD | 31.8% |
| 1995 Q1 | -305 Million USD | -11.72% |
| 1995 FY | -435 Million USD | -59.34% |
| 1995 Q3 | -343 Million USD | -64.9% |
| 1994 FY | -273 Million USD | 83.51% |
| 1994 Q1 | -1.68 Billion USD | -1.75% |
| 1994 Q2 | -1.34 Billion USD | 20.3% |
| 1994 Q4 | -273 Million USD | 39.2% |
| 1994 Q3 | -449 Million USD | 66.57% |
| 1993 Q3 | -1.72 Billion USD | -32.92% |
| 1993 Q1 | -1.13 Billion USD | 28.69% |
| 1993 Q4 | -1.65 Billion USD | 3.94% |
| 1993 Q2 | -1.29 Billion USD | -14.68% |
| 1993 FY | -1.65 Billion USD | -4.41% |
| 1992 Q1 | -591 Million USD | 20.88% |
| 1992 FY | -1.58 Billion USD | -112.32% |
| 1992 Q4 | -1.58 Billion USD | -275.83% |
| 1992 Q3 | -422 Million USD | -49.12% |
| 1992 Q2 | -283 Million USD | 52.12% |
| 1991 FY | -747 Million USD | -2434.38% |
| 1991 Q1 | -61 Million USD | -290.63% |
| 1991 Q2 | -519 Million USD | -750.82% |
| 1991 Q3 | -703 Million USD | -35.45% |
| 1991 Q4 | -747 Million USD | -6.26% |
| 1990 Q2 | -670 Million USD | -59.52% |
| 1990 FY | 32 Million USD | 300.0% |
| 1990 Q1 | -420 Million USD | -5350.0% |
| 1990 Q3 | -589 Million USD | 12.09% |
| 1990 Q4 | 32 Million USD | 105.43% |
| 1989 FY | 8 Million USD | 100.52% |
| 1989 Q4 | 8 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbbVie Inc. | 46.57 Billion USD | 35.582% |
| Bristol-Myers Squibb Company Ce | 30 Billion USD | 0.0% |
| Johnson & Johnson | 7.47 Billion USD | -301.445% |
| Eli Lilly and Company | 22.4 Billion USD | -33.889% |
| Merck & Co., Inc. | 29.35 Billion USD | -2.183% |
| Novartis AG | 12.95 Billion USD | -131.571% |
| Organon & Co. | 8.06 Billion USD | -271.885% |
| Pfizer Inc. | 72.18 Billion USD | 58.442% |